Tissue Repair Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical drug in Phase III clinical trial for the treatment of chronic wounds and venous leg ulcers; and TR Pro+, a post-procedure gel for the aftercare of acute wounds, and aesthetic and medical procedures. Tissue Repair Ltd was incorporated in 2012 and is based in Chatswood, Australia.
Key Metrics
PE ratio
-
PB ratio
0.89
Dividend yield
-
Beta
0.23
Market cap
$12.40M
Enterprise value
$-527831.00
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://tissuerepair.com.au |
| Mailing address | Tower A, The Zenith Level 9 821 Pacific Highway Chatswood NSW 2067 Australia |
| Phone / Fax | 61 4 2798 5805 / |
Dividends
More: Tissue Repair Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Tissue Repair paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.TRP dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Tissue Repair.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Tony Charara | Co-Founder, CEO & Executive Director | ||
| Mr. Dion Cohen | Chief Financial Officer | ||
| Dr. Darryl Reed | Chief Operating Officer | ||
| Mr. Gary Bird | Chief Commercial Officer | ||
| Ms. Sushma Kejriwal | Company Secretary |
Profitability and management effectiveness
Profit margin
-160.96%
Operating margin
-82.50%
Return on assets
-17.76%
Return on equity
-26.53%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Tissue Repair is 12.40M and its enterprise value is -527831.00. The enterprise value to revenue ratio of TRP is -0.20. The enterprise value to EBITDA ratio of TRP is 0.11.
The TRP's stocks Beta value is 0.23 making it 77% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Tissue Repair (TRP)
Tissue Repair (ASX:TRP) Frequently Asked Questions
1. What is Tissue Repair's Stock Symbol?
Tissue Repair trades on ASX under the ticker symbol "TRP".
2. What is Tissue Repair's stock price today?
One share of TRP stock can currently be purchased for approximately $0.205.
3. How can I contact Tissue Repair?
Tissue Repair's mailing address is Tower A, The Zenith Level 9 821 Pacific Highway Chatswood NSW 2067 Australia. The company can be reached via phone at 61 4 2798 5805.
4. What is Tissue Repair's official website?
The official website of Tissue Repair is https://tissuerepair.com.au.